Cyclacel Pharmaceuticals, Inc.

CYCCP | NASDAQ | 0 Sledující

$5.80

-1.69%

-$0.10

Sledovat

Overview Metrics Financials

Company Quality

Profitability Score

50/100

Solvency Score

75/100

Dividends

$0.15

Dividend Amount

3.00%

Dividend Yield

in 43 days

Next ex-date

in 54 days

Next payment date

Earnings

8/12/2025

in 65 days

Revenue est.

EPS est.

My Notes

You haven't added any notes for this stock yet. Use this space to record your insights or strategies.

Profile

Healthcare

Sektor

Biotechnology

Průmysl

Dr. Sing Ee Wong

CEO

Zaměstnanci

Berkeley Heights

Centrála

Země

Key Metrics TTM

Valuation

Market cap.

$8.2M

Enterprise Value

$4.8M

Price to Earnings

-0.31

Price to Sales

-392.4

Price to Book

0.65

Price to Cash Flow

-1.10

Profitability

Return on Assets

-168.96%

Return on Equity

-2,752.03%

Return on Invested Capital

-267.59%

Gross Margin

128.57%

Operating Margin

36,423.80%

Net Margin

30,043.00%

Liquidity

Quick Ratio

5.60

Current Ratio

5.60

Cash Ratio

5.20

Inventory Turnover

0.00

Asset Turnover

-0.0056

Total Liabilities

$672

Solvency

Debt to Assets

0.0024

Debt to Equity

N/A

Interest Coverage

-273.2

Equity Ratio

0.82

Long-term Debt to Cap.

0.00

Altman Z-Score

25,261

Performance

Earnings Waterfall

Debt level and coverage

Earnings

Feed

There are no posts to show right now.